Abingdon, UK, 11th June 2015, OBS Medical Limited (“OBS Medical”), is pleased to announce regulatory clearance to market Visensia – “The Safety Index” in Australia.
Read More...
Abingdon, UK, 21st May 2015, OBS Medical Limited (“OBS Medical”), is pleased to announce regulatory clearance to market Visensia – “The Safety Index” in Singapore.
Read More...
The Government has produced a set of policies which herald the most far reaching changes within the NHS since its inception in 1948. The White Paper published on July 12 2010 began to give some detail about the new landscape but left many areas unclear with a strong implication that the government expects people, not government to create ‘Big Society’.
Read More...
OBS Medical CEO – Peter Leyland, has been invited to attend this year’s 35th Annual Cowen Health Care Conference as a panel member for the Digital Therapeutics and Mobile Rx: Real World Applications and Emerging Business Models discussion.
Read More...